Endocrine Society

The Endocrine Society is a professional, international medical organization in the field of endocrinology and metabolism, founded in 1916 as The Association for the Study of Internal Secretions. The official name of the organization was changed to The Endocrine Society on January 1, 1952. It is a leading organization in the field and publishes four leading journals. It has more than 14,000 members from over 85 countries in medicine, molecular and cellular biology, biochemistry, physiology, genetics, immunology, education, industry and allied health. The Society's mission is: "excellence in hormone research and care of patients with endocrine disease".

Source: Wikipedia

Lobbying

$76,834 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Endocrine Society

View all lobbying data for Endocrine Society Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

4 Mentions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Endocrine Society" in public comments on proposed federal regulations.

  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 1 HHS HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act 2011
    • Toggle 1 FDA Refrain from Approving Any Abbreviated New Drug Application for Which Dovonex® Cream (calcipotriene 0.005%) is The Reference Listed Drug Until Certain Conditions Are Satisfied 2011
    • Toggle 1 CMS Changes to the Electronic Prescribing (eRx) Incentive Program 2011
    • Toggle 1 FDA Refrain From Approving any Abbreviated New Drug Application (ANDA) for Which Taclonex® Ointment (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%) and Taclonex Scalp® Topical Suspension (Calcipotriene 0.005% and Betamthasone Dipropionate 0.064%) is the Reference List Drug (RLD) Until the Following Conditions are Satisfied 2011